Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Using near-infrared brain light to help sub-clinical anxiety with attention bias work

Official title: Effects of Transcranial Photobiomodulation and Attention Bias Modification on Anxiety Symptoms and Brain Hemodynamics

Run by University of Texas at Austin · NCT07133893 · Data updated 2026-11-12

This study tests whether transcranial photobiomodulation with near-infrared light can help people with sub-clinical anxiety when paired with attention bias tasks, with or without a cognitive-behavioral component.

More Anxiety Symptoms trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment280 (estimated)
SponsorUniversity of Texas at Austin
Academic / other
Locations1 site (Austin, Texas)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 2027
Study endsSeptember 2028
Registry record updatedMay 14, 2026
Trial IDNCT07133893 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with STAI scores 40–59 and PHQ-9 scores 1–9, not currently on tPBM or with pregnancy, and without recent medication changes.

Probably not a fit

Individuals outside the 40–59 STAI or 1–9 PHQ-9 ranges, or those with recent medication changes, current tPBM treatment, or pregnancy, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research uses a single-blind, sham-controlled design to test transcranial photobiomodulation (tPBM) in adults with moderate sub-clinical anxiety. Participants complete attention bias assessment and modification while wearing an fNIRS headset to monitor brain activity, before and after tPBM or sham treatment. The study includes three in-person visits and a follow-up online, and uses block randomization to reduce bias. One aim is to evaluate tPBM as a standalone intervention, and the other as an adjunct to cognitive behavioral components of ABM. Outcomes are linked to changes in anxiety symptoms and brain activity.

Why it matters

Potential benefit: If successful, tPBM could offer a non-invasive way to reduce anxiety symptoms and enhance attention-bias interventions.

How similar studies have gone: Prior work suggests brain stimulation with light can influence cognition and emotion, but this specific combination with ABA/ABM and fNIRS in sub-clinical anxiety is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age and older
* State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
* Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)

Exclusion Criteria:

* STAI score less than 40 or greater than 59
* PHQ-9 score greater than 9
* Medication instability (i.e., medication change within 6 weeks)
* Indicated suicidal ideation
* Currently receiving tPBM treatment
* Current pregnancy

Where it's running

  • The University of Texas at Austin
    Austin, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.